Plus   Neg

Stock Alert: Quidel Stock Up 20% As FDA Approves New Antigen Test For COVID-19

Shares of Quidel Corp. (QDEL) are currently gaining over 20 percent on Monday morning after the U.S. Food and Drug Administration granted the company emergency-use authorization to its antigen test for the Covid-19 virus.

QDEL is currently trading at $190.61, up $32.01 or 20.18 percent, on the Nasdaq.

On Friday, FDA issued the authorization to market Quidel's Sofia 2 SARS Antigen FIA, a rapid point-of-care test to be used with the Sofia 2 Fluorescent Immunoassay Analyzer for the rapid detection of SARS-CoV-2.

An antigen test is a new type of diagnostic test designed for rapid detection of the virus that causes COVID-19. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Biotechnology company Seattle Genetics, Inc. (SGEN) and Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY, ALPMY) announced Friday that a phase 3 trial of PADCEV (enfortumab vedotin-ejfv) met its primary endpoint of overall survival compared to chemotherapy. The results were reviewed by... MWE Investments is recalling dual fuel portable generators citing fire risk, according to the U.S. Consumer Product Safety Commission. The recall involves about 7,500 units of Westinghouse WGen5300DFv Dual Fuel Portable Generators and Westinghouse iGen4500DF Dual Fuel Inverter Portable Generators. According to the agency, the dual fuel portable generators can leak fuel. Apple Inc. (AAPL) will launch an online store in India on September 23, offering the tech giant's full range of products and support directly to customers across the country for the first time.
Follow RTT